TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group - Université Sorbonne Paris Nord Accéder directement au contenu
Poster De Conférence Année : 2018

Dates et versions

hal-03965966 , version 1 (31-01-2023)

Identifiants

Citer

Giulia Tueur, Virginie Eclache, Grégory Lazarian, Carole Fleury, Rémi Letestu, et al.. TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group. Society of Hematological Oncoclogy (SOHO), Nov 2018, Houston (TX), United States. 18, pp.S218, 2018, ⟨10.1016/j.clml.2018.07.084⟩. ⟨hal-03965966⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More